Substantial increase in remdesivir production, allotment to states: Gowda

Union minister Sadananda Gowda on Saturday said that substantial increase has been made in overall production and allotment of remdesivir, used in the treatment of COVID-19, to all states.

remdesivir, coronavirus
Press Trust of India New Delhi
1 min read Last Updated : Apr 28 2021 | 5:02 PM IST

Union minister Sadananda Gowda on Saturday said that substantial increase has been made in overall production and allotment of remdesivir, used in the treatment of COVID-19, to all states.

This will make India's fight stronger against COVID-19, the Chemicals & Fertilizers Minister said.

In a tweet Gowda said, "After detailed review of state wise allotment of #Remdesivir with @Pharmadept substantial increase has been made in overall production & allotment to all states".

A total of 16 lakh remdesivir vials are being allocated to the states and union territories from April 21to April 30, 2021, Gowda said.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCorona RemediesHealth crisisD V Sadananda GowdaRemdesivir

First Published: Apr 24 2021 | 11:36 PM IST

Next Story